
FDA Warns Against Compounded Semaglutide for Diabetes, Weight Loss
FDA warns people to avoid using some forms of compounded substitutes of semaglutides that lack the safety and efficacy of popular weight loss drugs Wegovy, Ozempic, and Rybelsus. Continue Reading